O riginally developed in 1928, Raman spectroscopy has been used extensively to characterize molecular properties.
1 Surface-enhanced Raman spectroscopy (SERS) increases the Raman signal significantly 2Ϫ5 through enhanced electromagnetic fields in close proximity to a surface. Additional enhancement can be obtained by utilizing molecular resonance Raman (RR) effect when the molecule was excited at its absorption band. 6 SERS measurements performed on dispersed metal nanoparticle aggregates, which is the most commonly used SERS substrate, 7 have demonstrated detection sensitivity up to single molecule level. 8Ϫ10 However, these measurements often suffer from poor reproducibility. 11 To improve the reproducibility, other methods, including self-assembly of metallic colloidal nanoparticles, 12 nanosphere lithography (NSL) and metal film over nanosphere (MFON), 13 electrochemical roughening of polished gold substrate, 14 and periodic structured metallic substrate using electron-beam lithography, 15 have been developed to fabricate a SERS substrate consisting of homogeneous features over a large area with reproducible enhancement factors up to 10 8 . Although these efforts lead to successful utilization of SERS analysis in many promising applications, including gene and protein discrimination, 16Ϫ18 biowarfare agent detection, 19 and real-time glucose monitoring, 20 the inability to fabricate SERS hot-spots at a specific location limits application for a very small sample volume. To overcome such a limit, we recently developed tunable nanoplasmonic resonators (NPRs), consisting of a thin SiO 2 layer sandwiched between metallic nanodisks. 21 The resonance frequency can be precisely tuned by varying the dielectric layer thickness and aspect ratio of the NPRs. Individual NPRs can enhance the Raman intensity by a factor of 6.1 ϫ 10 10 , among the largest values obtained for a single SERS substrate or nanoparticle. Fabricated using well-established nanolithography processes, the NPR-based method enables producing SERS hot-spots at a desired location in a much smaller dimension reproducibly, allowing multiplexed high-throughput detection and labon-chip applications.
Prostate cancer biomarker, prostatespecific antigen (PSA), a kallikrein (hK) family serine protease, 22, 23 is used as the model protease in this study. The commonly used PSA blood test has been widely used for early diagnosis and management of prostate cancer, the leading male cancer. 24, 25 However, serum PSA concentrations reflect the presence of benign prostatic hyperplasia (BPH) more often than cancer. 26, 27 The lack of specificity causes a high false-positive rate and often leads to costly prostate needle biopsies for diagnosis and postbiopsy complications as well as considerable anxiety. 22, 28, 29 Recent research has identified a family of highly specific peptides that can be cleaved by paPSA isoform in xenograft models 30 and human samples; 31, 32 thus, measurement of paPSA protease activity from in vivo samples is possible and would be potentially valuable as a more specific screening agent for prostate cancer and in detection of recurrent disease. However, reported results based on immunopeptidemetric assays (IMPA) exhibit low fluorescence signal-to-noise ratios, preventing reliable measurements at lower concentrations in the clinically important range of 60Ϫ300 pM. 31, 32 In addition,
there is usually a limited number of prostate cancer cells (Ͻ1000) isolated from fine needle biopsy or circulating cell capture. No method exists that can perform a paPSA protease activity assay on a small number of cells for clinical staging. Therefore, a key goal of this work is to develop an NPR-based method that allows specific and sensitive measurements of paPSA for prostate cancer detection in a very small sample volume.
RESULTS AND DISCUSSION
In this work, NPRs ( Figure 1a ) were conjugated with a PSA protease-specific substrate peptide, which has the sequence R19-HSSKLQLAAAC, 30, 33 with the SERS molecule Rhodamine 19 (R19) at the N-terminus and cysteine at the C-terminus ( Figure  1b) . The peptide has been identified as a highly specific peptide that can be cleaved by paPSA in vivo in xenograft models 30 and human samples. 31, 32 The paPSA cleaves the peptide, leading to the release of the R19 moiety ( Figure 1c ) and a subsequent decrease in the Raman scattering intensity in a doseand time-dependent manner, and the PSA protease activity can be accurately quantified. It has been theoretically estimated that SERS enhancement is strongly localized to the vicinity of nanoparticle resonator surface (5Ϫ10 nm), which effectively eliminates the assay background noise from the Raman scattering substance in the surrounding fluids or the R19 moieties that diffuse into the solution after protease cleavage. Because of this unique property, the assay can be performed in a simplified one-step format with no additional washing step required.
Under an optical microscope, the NPR arrays were distinctly visible due to the strong scattering of light at their resonant wavelength (Figure 2a ). The magnified views of NPR arrays measured by scanning elec- www.acsnano.org B tron microscopy (SEM) and atomic force microscopy (AFM) are shown in Figure 2b ,c. The optical properties of the NPR were characterized by illuminating the NPRs with collimated light delivered by a multimode optical fiber from a 150 W xenon lamp (Thermo Oriel), and the extinction spectra were collected using a grating spectrometer (Triax 550, Jobin Yvon) with a matched liquid nitrogen cooled CCD detector (CCD-3500, Jobin Yvon). 21 The SiO 2 layer, sandwiched between the Ag layers, enabled precisely tuning of the NPR resonance. As shown in Figure 2d , the measured resonance peak of NPRϪpeptideϪR19 conjugates closely matches the laser excitation wavelength at 532 nm and, thus, maximizes the enhancement of Raman scattering. It is worthwhile to note, at the laser excitation overlap with the R19 absorption band centered at 517 nm, the resulting resonant Raman scattering may also contribute to the enhanced Raman signal. For the SERS experiments, Raman spectra were measured using a modified inverted microscope (Axiovert 200, Zeiss) with a 50ϫ objective in a backscattering configuration. As shown in Figure 2e , the NPR-based SERS substrate exhibits a reproducible Raman spectrum with consistent enhancement factor at the same order of magnitude. The variation of experimentally measured SERS intensities obtained from six different NPR arrays is below 25%, and it can be easily normalized in the experiment.
The assay was performed by exposing the NPRϪpeptideϪR19 nanosensor to the fluidic samples, and the subsequent time-dependent R19 Raman spectra change was recorded at an interval of 1 min and an integration time of 30 s. The Raman peak at 1316 cm Ϫ1 of SERS label molecule (R19) was monitored as the primary signature peak in this study, while the 1456, 1526, and 1597 cm Ϫ1 peaks were also monitored as additional references (Figure 3) . The time-resolved spectral measurement in the presence of PSA (Figure 3a ) is plotted in Figure  3c . Because the SERS intensities are proportional to the remaining R19 on the NPR surface, the normalized SERS intensity change is a direct indicator of PSA activity. Despite the variation in the initial intensity of different Raman signature peaks, the normalized data all converged into the same curve, indicating that the normalized SERS intensity change is a reliable measure to quantitatively determine the substrate peptide being cleaved. As shown in Figure 3c , before PSA addition, the NPR nanosensor showed steady intensities for all of the peaks over a 10 min period. However, upon addition of PSA, a significant decrease in each Raman peak is observed in the first 10Ϫ12 min, indicating that the PSA pro- ARTICLE www.acsnano.org VOL. XXX ▪ NO. XX ▪ 000-000 ▪ XXXX tease was able to cleave the peptides on the NPR. At the end point of 30 min, the decrease of the Raman signal reaches a plateau at a PSA concentration of 6 nM, while at a lower concentration level (ϳpM), the signal continues to decrease at a much lower rate. Another serine protease, granzyme B, was selected as a negative control (Figure 3b,c) . Within 50 min of recording, no substantial changes in SERS intensity were observed, even at concentrations up to 1 M. This result demonstrates that the decrease of Raman signal in the PSA assay was based on a genuine enzymatic process, rather than a nonspecific hydrolysis reaction or due to the displacement of the peptide from the surface by other components in the buffer. The sensitivity of the NPR nanosensor was evaluated by measuring the SERS intensity change of a set of samples with the PSA enzyme concentration ranging from 6 nM to 6 pM. The absolute value of normalized SERS intensity change is shown in Figure 4a . As expected, the rate of decrease in the Raman signal was proportional to the concentration of PSA, which is explained by a reduced rate of peptide cleavage when the PSA concentrations are decreased. The proteolytic activity eventually reaches an equilibrium stage at 30 min, as indicated by each Raman signal reaching a plateau. The absolute value of normalized decrease in SERS intensity versus various concentrations, after 30 min of enzyme addition, is plotted in Figure 4b . The dynamic range for detection, in the current assay setup, was from 6 pM to 6 nM. PSA concentration higher than 6 nM does not exhibit a distinct difference with the given detection time. As shown in Figure 4c , the monitored Raman peak intensity exhibits distinguishable decay characteristics at different PSA concentrations during the initial 4 min of sampling. Thus, by fitting the decaying rate, reliable assays can possibly be accomplished in 4 min.
In addition to protease activity measurements of purified PSA, measurements for PSA protease activity in extracellular fluid (ECF) from live cell culture were performed (Figure 4d ). It is well-known that LNCaP cells secrete PSA and have recently been used in xenografts to evaluate in vivo PSA concentration. 30 For comparison, a K562 cell line, which does not secrete PSA into the ECF, was used as a negative control. LNCaP ECF showed a significant change in SERS signal, while K562 exhibits very low PSA enzymatic activity (Figure 4d) . By correlating the normalized decrease in Raman signal with Figure 3b , it was determined that the LNCaP media had an elevated amount of paPSA concentration (Figure 4d ).
SUMMARY
Compared with fluorescence-based assay, the NPRbased method offers several advantages. Strongly localized Raman enhancement can substantially amplify the signal and also effectively reduce background noise. Therefore, it allows one-step and label-free detection of protease activity with sensitivity at 6 pM and a dynamic range of 3 orders of magnitude. It should be noted that PSA is considered a weak protease, and other proteases would allow even better sensitivity. Second, it allows accurate measurement with a very small sample volume of 15 pL (Supporting Information). Third, fabricated using a well-established nanolithography process, the NPR-based method is highly reproducible and thus allows quantitative assessment of protease activity. Finally, NPRs can be spatially arranged in a microarray format to achieve multiplexed measurements with broad applications, by measuring all known proteases in unprocessed biological samples without complex sample processing and purification steps. The multiplexity of the substrate peptide spatially www.acsnano.org D can be achieved with a microarrayer with industry standard protocols when combined with NPR nanoarray clusters arranged in the microarray format. Even if each of the 500ϩ proteases are cross-interrogated by 10 different substrate peptides, the array still has an easily manageable feature number of less than 10 000.
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MATERIALS AND METHODS
NPR Fabrication. The NPR was patterned on quartz substrates (HOYA Corp.) by electron beam lithography (EBL) (Nanowriter Series EBL 100, Leica Microsystems). A 30 nm thick indiumϪtinϪoxide (ITO) under-layer was sputtered on the substrate to prevent charging effects during the EBL process. A 100 nm thick polymethylmethacrylate (PMMA, MicroChem Corp.) film spin-coated on the ITO-quartz glass was used as a positive photoresist. After exposure, the patterns were developed using a 1:3 ratio of a MIBK and IPA mixture followed by multilayer deposition of metal and dielectric materials using electron beam evaporation (Mark 40, CHA) and standard lift-off procedures. We fabricated three layered Ag/SiO 2 /Ag NPR arrays with each silver and SiO 2 layer thickness equal to 25 and 5 nm, respectively. The geometry of the fabricated NPR was examined by atomic force microscopy, and the total thickness of the NPR is confirmed to be 55 nm.
Device Design and Characterization. The optical properties of the NPR were characterized by illuminating the NPRs with collimated light delivered by a multimode optical fiber from a 150 W xenon lamp (Thermo Oriel) and collecting the extinction spectra using a grating spectrometer (Triax 550, Jobin Yvon) with a matched liquid nitrogen cooled CCD detector (CCD-3500, Jobin Yvon). For the SERS experiments, Raman spectra were measured using a modified inverted microscope (Axiovert 200, Zeiss) with a 50ϫ objective in a backscattering configuration. Baseline subtraction was applied to remove the fluorescence background of the measured spectra. The spectra were then smoothed in Matlab using the SavitskyϪGolay method with a second-order polynomial and window size of 9. To correct the possible influence due to the fluctuation of illumination intensity, frequency dependence of Raman scattering, and the variation of initial packing density of the reported molecules, the change in SERS intensity was normalized to the average intensity before protease addition. The normalized SERS intensity change is defined as where I 0 is the average SERS intensity before the addition of the protease and I t is the SERS intensity measured at the given time t. Peptide Conjugation to NPR and Applying Sample. The peptide attaches to the NPR via the thiol group on cysteine. The PSA substrate peptides were mixed with octanethiol at a 1:3 ratio and at a concentration of 50 M. Octanethiol, with a SAM chain length of 1Ϫ2 nm, was used as packing material to manage the distance among the PSA substrate peptides and help to erect the PSA substrate peptide for optimal spatial presentation. Thus, the octanethiol SAM improves access for the protease to bind to the peptides. The peptide solution was incubated with the NPR substrate for 24 h to ensure a well-ordered self-assembled monolayer on the NPR metallic surface. During incubation, the sample was kept at 20°C. Before incubation with the PSA enzyme, the sample was washed repeatedly with deionized water to ensure that all of the unattached peptides were removed. Upon washing, the sample was incubated with a sample in a Tris-HCl, pH 8.0, 100 mM NaCl, and 0.1 mM EDTA buffer. Incubation was performed by placing a 100 L drop of the sample on the NPR array. SERS measurements were performed directly after incubation at 1 min intervals.
Cell Culture and Clinical Semen Samples. LNCaP cells actively secrete PSA into ECF, and the human CML cells K562 are negative for PSA. Both cell lines are maintained in RPMI-1640 with 10% FBS and 1ϫ Pen/Strep, at 37°C with 5% CO 2 ; 10 ϫ 10 6 cells were cultured overnight in 10 mL of fresh media. Media from both cultures were collected, and PSA activity was measured by fluorescent methods as described before and calibrated against commercial PSA (Calbiochem, San Diego, CA). Briefly, the PSAbinding peptides and derivatives with a spacer were chemically synthesized and used to prepare an affinity column, which was used to fractionate PSA in seminal plasma.
Purified PSA Preparation and Proteolytic Reaction. Proteolytically active PSA was purified to homogeneity from human seminal plasma by column chromatography, eliminating all known PSA complexes and retaining its protease fraction. Cleavage of the substrate peptide immobilized on the NPR nanosensor is performed in a buffer of 50 mM Tris-HCl, pH 8.0, 100 mM NaCl, and 0.1 mM EDTA, and the reaction was monitored in real-time in 37°C. Protease inhibitors (to prevent PSA and granzyme B degradation) were obtained from CalBiochem and added to the reaction mixture following the manufacturer's instructions, so that the final reaction solution contains 5 M AEBSF, 4.2 nM Aprotinin, 200 nM Elastatinal, and 10 nM GGACK. The concentration of proteolytically active PSA in the PSA reagent has been prepared with a wide range of concentration from 6 pM to 6 nM.
